Novel Causative Variants in DYRK1A, KARS, and KAT6A Associated with Intellectual Disability and Additional Phenotypic Features

 

 Buy Article Permissions and Reprints

Abstract

Patients with unclear patterns of developmental and cognitive delay may go years without a definitive diagnosis despite extensive testing due to overlapping phenotypes of many genetic disorders. In this study, we identified causative variants in DYRK1A, KARS, or KAT6A in four individuals with global developmental delay and various findings including microcephaly and sensorineural hearing loss using whole exome sequencing. We present the cognitive, neurologic, and physical findings of four individuals to expand the clinical knowledge of possible features of the phenotypes of three rare genetic disorders. Through this process, we provide support for the use of whole exome sequencing in the setting of severe, intellectual disability or in those in whom a genetic disorder is suspected despite initial negative testing.

Web Resources

ClinVar: http://www.ncbi.nlm.nih.gov/clinvar/

Exome Aggregation Consortium (ExAC): http://exac.broadinstitute.org/

1000 Genomes: http://www.1000genomes.org/

NHLBI GO Exome Sequencing Project (ESP): http://evs.gs.washington.edu/EVS/

Polyphen2: http://genetics.bwh.harvard.edu/pph2/

SIFT: http://sift.jcvi.org/

Combined Annotation Dependent Depletion (CADD): http://cadd.gs.washington.edu/

Protein Variation Effect Analyzer (PROVEAN): http://provean.jcvi.org/index.php

• References

• 1 Miller DT, Adam MP, Aradhya S , et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86 (5) 749-764
  CrossrefPubMedGoogle Scholar
• 2 Hochstenbach R, van Binsbergen E, Engelen J , et al. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet 2009; 52 (4) 161-169
  CrossrefPubMedGoogle Scholar
• 3 Rauch A, Wieczorek D, Graf E , et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012; 380 (9854): 1674-1682
  CrossrefPubMedGoogle Scholar
• 4 de Ligt J, Willemsen MH, van Bon BW , et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012; 367 (20) 1921-1929
  CrossrefPubMedGoogle Scholar
• 5 Bademci G, Foster II J, Mahdieh N , et al. Comprehensive analysis via exome sequencing uncovers genetic etiology in autosomal recessive nonsyndromic deafness in a large multiethnic cohort. Genet Med 2016; 18 (4) 364-371
  CrossrefPubMedGoogle Scholar
• 6 Richards S, Aziz N, Bale S , et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (5) 405-424
  CrossrefPubMedGoogle Scholar
• 7 Aljuani F, Tournadre A, Cecchetti S, Soubrier M, Dubost JJ. Macro-creatine kinase: a neglected cause of elevated creatine kinase. Intern Med J 2015; 45 (4) 457-459
  CrossrefPubMedGoogle Scholar
• 8 Møller RS, Kübart S, Hoeltzenbein M , et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet 2008; 82 (5) 1165-1170
  CrossrefPubMedGoogle Scholar
• 9 van Bon BW, Coe BP, Bernier R , et al. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol Psychiatry 2016; 21 (1) 126-132
  CrossrefPubMedGoogle Scholar
• 10 Luco SM, Pohl D, Sell E, Wagner JD, Dyment DA, Daoud H. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature. BMC Med Genet 2016; 17: 15 DOI: 10.1186/s12881-016-0276-4.
  CrossrefPubMedGoogle Scholar
• 11 Santos-Cortez RL, Lee K, Azeem Z , et al; University of Washington Center for Mendelian Genomics. Mutations in KARS, encoding lysyl-tRNA synthetase, cause autosomal-recessive nonsyndromic hearing impairment DFNB89. Am J Hum Genet 2013; 93 (1) 132-140
  CrossrefPubMedGoogle Scholar
• 12 McLaughlin HM, Sakaguchi R, Liu C , et al; NISC Comparative Sequencing Program. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet 2010; 87 (4) 560-566
  CrossrefPubMedGoogle Scholar
• 13 McMillan HJ, Humphreys P, Smith A , et al; FORGE Canada Consortium. Congenital visual impairment and progressive microcephaly due to lysyl-transfer ribonucleic acid (RNA) synthetase (KARS) mutations: the expanding phenotype of aminoacyl-transfer RNA synthetase mutations in human disease. J Child Neurol 2015; 30 (8) 1037-1043
  CrossrefPubMedGoogle Scholar
• 14 Lieber DS, Calvo SE, Shanahan K , et al. Targeted exome sequencing of suspected mitochondrial disorders. Neurology 2013; 80 (19) 1762-1770
  CrossrefPubMedGoogle Scholar
• 15 Arboleda VA, Lee H, Dorrani N , et al; UCLA Clinical Genomics Center. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. Am J Hum Genet 2015; 96 (3) 498-506
  CrossrefPubMedGoogle Scholar
• 16 Tham E, Lindstrand A, Santani A , et al. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. Am J Hum Genet 2015; 96 (3) 507-513
  CrossrefPubMedGoogle Scholar
• 17 Millan F, Cho MT, Retterer K , et al. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder. Am J Med Genet A 2016; 170 (7) 1791-1798
  CrossrefPubMedGoogle Scholar
• 18 Lee H, Deignan JL, Dorrani N , et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 2014; 312 (18) 1880-1887
  CrossrefPubMedGoogle Scholar
• 19 Wright CF, Fitzgerald TW, Jones WD , et al; DDD study. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet 2015; 385 (9975): 1305-1314
  CrossrefPubMedGoogle Scholar
• 20 Yang Y, Muzny DM, Reid JG , et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013; 369 (16) 1502-1511
  CrossrefPubMedGoogle Scholar
• 21 Yang Y, Muzny DM, Xia F , et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014; 312 (18) 1870-1879
  CrossrefPubMedGoogle Scholar
• 22 Gilissen C, Hehir-Kwa JY, Thung DT , et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014; 511 (7509): 344-347
  CrossrefPubMedGoogle Scholar
• 23 Retterer K, Juusola J, Cho MT , et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med 2016; 18 (7) 696-704
  CrossrefPubMedGoogle Scholar
• 24 Johansen Taber KA, Dickinson BD, Wilson M. The promise and challenges of next-generation genome sequencing for clinical care. JAMA Intern Med 2014; 174 (2) 275-280
  CrossrefPubMedGoogle Scholar
• 25 O'Roak BJ, Deriziotis P, Lee C , et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011; 43 (6) 585-589
  CrossrefPubMedGoogle Scholar